GHRP-6

Research Phase

Growth Hormone Releasing Peptide-6

Category
Growth Hormone
Aliases
GHRP-6
Administration
Subcutaneous injection

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    A pronounced increase in appetite is typically the earliest and most noticeable effect, often within the first doses.

  2. 2

    3–4 Weeks

    Some users report early improvements in sleep and recovery alongside the continued appetite effect.

  3. 3

    5–7 Weeks

    Continued use is commonly associated with steadier recovery, though the appetite effect generally persists throughout use rather than fading.

  4. 4

    8–10 Weeks

    Gradual changes in body composition may begin to be noticed by consistent users, particularly when the increased appetite is channeled into structured eating.

  5. 5

    11–15 Weeks

    Effects are generally described as consistent through this window for users who continue dosing.

  6. 6

    16–20 Weeks

    This period is often described as when composition changes feel most noticeable among long-term users.

  7. 7

    21–24 Weeks

    Users typically assess whether to continue, adjust, or cycle off by this stage.

⚠️ Research context only. This is not medical advice and results are not guaranteed.